Overview & Neuro-Regenerative Care
Investigational Stem Cell Therapy for Alzheimer’s Disease in India • Mesenchymal Cell Protocols, Neuroprotection & Quality of Life Enhancement
Alzheimer’s disease is a progressive neurological condition characterized by memory loss, cognitive decline, and reduced functional independence. While there is currently no universal cure, our partner medical centers in India provide investigational regenerative medicine protocols. Using mesenchymal stem cells (MSCs) and neuroprotective secretomes, protocols focus on modulating neuroinflammation, supporting remaining brain cells, and enhancing patient quality of life alongside standard neurological care.
Stem cell therapy for Alzheimer’s disease is an investigational and adjuvant clinical strategy. It is formulated to slow cognitive decline, protect surviving neuronal circuitry, and attenuate neuroinflammation—this is not an established clinical cure.
Mesenchymal stem cells (MSCs) operate primarily through paracrine trophic signaling—releasing neurotrophic factors (such as BDNF, VEGF, and IGF-1) and immunomodulatory cytokines. These signaling molecules actively downregulate microglial neuroinflammation, mitigate toxic microenvironments, and support synaptic resilience.
Source Distinctions & Donor Screening Rigor
Certified autologous harvesting and ethically screened allogeneic umbilical cord tissue processed in ISO Class 5 cleanrooms
Cellular safety, potency, and sterility are paramount in neurological applications. Our partner centers adhere to strict bio-processing protocols, giving families clear distinction between autologous and allogeneic cellular options:
Autologous Bone Marrow / Adipose MSCs
Harvested from the patient’s own bone marrow or adipose tissue. Completely eliminates foreign immunological reactions and graft rejection, but requires an invasive collection procedure under local anesthesia.
Umbilical Cord Matrix (Wharton's Jelly MSCs)
Ethically sourced from healthy, screened full-term maternal donors post-caesarean delivery. Processed in ISO Class 5 cleanrooms without requiring any invasive surgical harvesting from the senior patient.
Mandatory Donor Safety Testing & Quality Release Standard
Multidisciplinary Patient Candidacy Evaluation
Potential Improvements Monitored Post-Therapy
Evaluating neurological stability, functional preservation, and overall quality of life under structured medical monitoring
When tracking patient responses following Mesenchymal Stem Cell (MSC) therapy for Alzheimer’s disease, clinical teams evaluate neurological stability, functional independence, and overall quality of life. Because Alzheimer’s is a progressive neurodegenerative condition, therapy aims primarily at neuroprotection, systemic immunomodulation, and functional preservation rather than a complete disease reversal.
Clinical Observation Timeline: When Are Changes Noticed?
Cellular trophic signaling effects typically take 4 to 12 weeks to manifest in daily behavior, cognitive test scores, or mood stability. Because Alzheimer’s is an underlying progressive condition, any therapeutic benefits observed are not permanent and require structured monitoring over 6 to 12 months.
Why Choose Our Centers in India?
Hospital infrastructure, accreditation, specialized neurology leadership, and international patient care:
| Quality Metric | What Our Partner Centers Provide |
|---|---|
| Accredited Infrastructure | Procedures performed exclusively within tertiary hospitals accredited by JCI (Joint Commission International) and NABH. |
| Neurology Leadership | Care directed by board-certified neurologists (DM/DNB) with specialized expertise in memory disorders and neuro-regeneration. |
| cGMP Cleanroom Quality | Cell isolation and characterization conducted in ISO Class 5 / Grade A cleanrooms with ≥90% post-thaw viability and sterility certification. |
| Ethical & ICMR Compliance | Strict adherence to Indian Council of Medical Research (ICMR) and CDSCO stem cell guidelines under active Institutional Ethics Committee (IEC) oversight. |
| Multidisciplinary Support | Simultaneous access to physical therapy, cognitive rehabilitation, clinical psychologists, speech pathology, and clinical nutritionists. |
| Financial Transparency | Clear, bundled international package pricing with zero hidden procedural surcharges and up to 80% cost savings compared to private Western clinics. |
Treatment Costs & Package Inclusions
Clear, transparent international package pricing with comprehensive inpatient inclusions:
(individual pricing depends on autologous vs. allogeneic protocols, cell dosage, and required supportive therapies).
(Aimed at slowing cognitive decline, modulating neuroinflammation, and supporting daily functional independence).
| Country / Region | Typical Package Range | Waiting Period | Clinical Accreditation |
|---|---|---|---|
| India (Our Partner Centers) | $4,500 – $7,500 USD | 1 – 2 Weeks | JCI / NABH Accredited |
| United States | $25,000 – $50,000 USD | 3 – 6 Months | Clinical Trial Gated |
| United Kingdom & EU | $22,000 – $40,000 USD | 2 – 5 Months | Private Specialty Only |
| Panama / Mexico | $18,000 – $35,000 USD | 2 – 4 Weeks | Variable Regional |
Special Services for International Patients
Comprehensive cross-border medical assistance, visa clearance, and dedicated bilingual support
Dedicated End-to-End International Concierge
Traveling abroad for Alzheimer's regenerative care requires precise coordination. Our international liaison desk provides round-the-clock administrative, clinical, and linguistic support from initial review to long-term recovery.
Complimentary Remote Triage
Pre-travel review of brain MRI/CT scans, MMSE/MoCA cognitive scores, and neurological history by an assigned senior neurologist before you commit to travel.
Medical Visa (M-Visa) Support
Official government-registered hospital invitation letters and visa processing guidance for patients and accompanying family caregivers issued within 24 hours.
Dedicated Care Coordinator
A single designated point of contact providing 24/7 personal assistance, scheduling appointments, handling reports, and assisting with hospital formalities.
Language Interpretation
On-site professional medical translation support for English, Arabic, Russian, and French, ensuring effortless doctor-patient communication.
Logistics, Accommodations & Senior Comfort
Carefully curated hospitality and wheelchair-friendly transit tailored for Alzheimer's patients and families
Designed for Safety, Comfort & Mobility
We recognize that unfamiliar environments can cause disorientation for Alzheimer's patients. Our logistics setup prioritizes calm surroundings, step-free access, and seamless transit to minimize agitation.
Private Airport Transfers
Direct tarmac assistance and wheelchair-accessible private chauffeur pickup directly from New Delhi (DEL) or Mumbai (BOM) international terminals to your hospital/hotel.
Curated Accommodations
Pre-negotiated partner 4-star and 5-star hotels or serviced apartments within a 10–15 minute radius of the hospital, equipped with senior-friendly layouts.
Senior-Friendly Amenities
Step-free wheelchair access, quiet calming room surroundings, customized dietary meal plans, and optional on-demand bedside nursing support upon request.
Daily Hospital Transit
Comfortable, prompt chauffeur-driven round-trip transit between your partner hotel residence and the hospital department for every consultation and therapy session.
Your Step-by-Step Patient Journey
A transparent, structured 6-phase clinical roadmap from pre-travel evaluation to long-term follow-up
A transparent, structured patient journey reduces travel anxiety, sets clear expectations, and ensures clinical safety at every stage. For an international patient traveling to India for stem cell therapy, the care pathway spans three distinct phases: Pre-Travel Evaluation, In-Hospital Protocol, and Long-Term Continuum of Care.
Initial Case Review & Remote Eligibility Assessment
Conducted remotely prior to any international travel commitments:
Treatment Plan, Cost Transparency & Travel Preparation
Ensures complete administrative clarity before departure:
Arrival in India & Pre-Procedure Baseline Diagnostics
First 24 to 48 hours on the ground:
Cellular Protocol & Monitored Administration
Conducted under sterile hospital operating theater conditions:
Rehabilitation, Discharge & Fit-to-Fly Clearance
Prior to international departure:
Structured Remote Follow-Up & Long-Term Continuum
Long-term recovery tracking over 6 to 12 months:
Cellular Quality Release & Safety Protocols
Certified cleanrooms, multi-tier sterility cultures, and flow cytometry characterization
cGMP Cleanroom Processing
All cellular isolation and cryopreservation take place inside ISO Class 5 / Grade A biosafety laminar flow cleanrooms with HEPA air filtration and continuous airborne particle monitoring.
Flow Cytometry Characterization
Mesenchymal identity is certified via flow cytometry confirming positive ISCT surface markers (≥95% CD73, CD90, CD105) and negative hematopoietic markers (≤2% CD34, CD45, HLA-DR).
Sterility & Endotoxin Release
Every clinical batch undergoes rapid 14-day USP bacterial and fungal automated cultures, mycoplasma PCR, and LAL endotoxin testing (<0.5 EU/ml) before procedural release.
Institutional Ethics Approval
Protocols operate under independent Institutional Ethics Committees (IEC) registered with the Central Drugs Standard Control Organisation (CDSCO), Government of India.
Frequently Asked Questions
Direct medical answers regarding Alzheimer's stem cell protocols, realistic outcomes, and travel
While it is not a permanent cure, stem cell therapy focuses on significantly slowing down cognitive decline and helping patients preserve their memory for longer. The treatment works to repair damaged neural pathways, aiming to deeply improve your loved one's daily quality of life (Duan et al., 2023).
Stem cells actively reduce harmful brain inflammation and release special proteins that protect existing neurons from further damage. This process also helps clear out the toxic amyloid plaques associated with Alzheimer's, creating a much healthier environment for brain function (Xie et al., 2023).
Absolutely. We primarily use adult stem cells, making the procedure minimally invasive and exceptionally safe for seniors. Clinical trials consistently show that it avoids the harsh side effects of heavy medications while focusing entirely on natural cellular repair (Liu et al., 2020).
Every patient’s journey is unique, but many families report noticing subtle improvements in mood, awareness, and memory retention within 3 to 6 months. The therapy works gradually, gently supporting the brain as it attempts to rebuild lost connections over time.
Patients who are currently in the mild to moderate stages of Alzheimer's tend to experience the most meaningful and lasting benefits from this therapy. Our medical specialists always conduct a comprehensive health review to ensure this treatment is the safest, most effective path forward for your family.
We highly recommend continuing your current FDA-approved medications and cognitive therapies alongside the stem cell treatment. Think of stem cell therapy as a powerful, complementary boost to your existing care plan that works quietly behind the scenes to maximize results (Ahmad & Sachdeva, 2022).
Peer-Reviewed Scientific Citations & Clinical References
Key published clinical trials, studies, and peer-reviewed literature supporting cellular therapy and neuroprotective protocols in Alzheimer's Disease: